» Articles » PMID: 16093313

Specific Inhibition of CBP/beta-catenin Interaction Rescues Defects in Neuronal Differentiation Caused by a Presenilin-1 Mutation

Overview
Specialty Science
Date 2005 Aug 12
PMID 16093313
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Wnt/beta-catenin signaling has been shown to promote self-renewal in a variety of tissue stem cells, including neuronal stem cells and hematopoietic stem cells. However, activation of the Wnt/beta-catenin pathway promoted and inhibition of the pathway prevented differentiation of neuronal precursor cells. A clear explanation for the differential effects of Wnt/beta-catenin activation on neuronal precursors is not available at present. Presenilin-1 (PS-1) is a polytopic protein comprised of six to eight transmembrane domains. PS-1, as part of the gamma-secretase complex, is required for the intramembrane proteolysis of both amyloid precursor protein (APP) and Notch. Additionally, through interactions with beta-catenin, PS-1 is associated with modulation of Wnt/beta-catenin signaling. A familial Alzheimer's disease-associated PS-1 mutant, PS-1(L286V), causes a dramatic increase in T cell factor (TCF)/beta-catenin transcription in PC-12 cells, which prevents normal nerve growth factor (NGF)-induced neuronal differentiation and neurite outgrowth. Selective inhibition of TCF/beta-catenin/cAMP-response element-binding protein (CREB)-binding protein (CBP)-mediated transcription, but not TCF/beta-catenin/p300, with the recently described small molecule antagonist ICG-001 corrects these defects in neuronal differentiation, highlighting the importance of Wnt/beta-catenin signaling in this process. We propose that increased TCF/beta-catenin/CBP-mediated transcription, as well as a failure to switch to TCF/beta-catenin/p300-mediated transcription, play an important role in decreasing neuronal differentiation.

Citing Articles

Targeting CBP and p300: Emerging Anticancer Agents.

Masci D, Puxeddu M, Silvestri R, La Regina G Molecules. 2024; 29(19).

PMID: 39407454 PMC: 11482477. DOI: 10.3390/molecules29194524.


Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?.

de Pellegars-Malhortie A, Picque Lasorsa L, Mazard T, Granier F, Prevostel C Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065798 PMC: 11279613. DOI: 10.3390/ph17070949.


3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer.

Zhou Y, He Z, Li T, Choppavarapu L, Hu X, Cao R Cancers (Basel). 2024; 16(12).

PMID: 38927910 PMC: 11201718. DOI: 10.3390/cancers16122202.


Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia.

Park C, Yoshihara H, Gao Q, Qu C, Iacobucci I, Ghate P Cell Rep. 2023; 42(7):112804.

PMID: 37453060 PMC: 10529385. DOI: 10.1016/j.celrep.2023.112804.


Anti-inflammatory and antifibrotic effects of CBP/β-catenin inhibitor for hepatocytes: small molecular inhibitor, OP-724 possibly improves liver function.

Ouchi H, Mizutani Y, Yoshimura K, Sato Y, Kimura K, Haruyama Y Med Mol Morphol. 2023; 56(2):94-105.

PMID: 36645521 DOI: 10.1007/s00795-022-00343-8.


References
1.
Tischler A, Greene L . Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells. Nature. 1975; 258(5533):341-2. DOI: 10.1038/258341a0. View

2.
Yao T, P Oh S, Fuchs M, Zhou N, ChNg L, Newsome D . Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 1998; 93(3):361-72. DOI: 10.1016/s0092-8674(00)81165-4. View

3.
Behrens J . Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci. 2000; 910:21-33; discussion 33-5. DOI: 10.1111/j.1749-6632.2000.tb06698.x. View

4.
Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View

5.
Otero J, Fu W, Kan L, Cuadra A, Kessler J . Beta-catenin signaling is required for neural differentiation of embryonic stem cells. Development. 2004; 131(15):3545-57. DOI: 10.1242/dev.01218. View